0
2018
Antibiotics Market

Antibiotics Market

by Class (Beta Lactam & Beta Lactamase, Quinolones, Macrolides, and Others), Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic and Narrow-spectrum Antibiotic), and Route of Administration (Oral, Intravenous, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Report Code: A04710
Pages: 282
Oct 2018 | 18996 Views
Author(s) : Onkar S, Tenzin K, and P
Tables: 140
Charts: 54
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Antibiotics Market

Request Now !

Antibiotics Market Overview :

Antibiotic is an antimicrobial substance, which combats bacterial infections and occasionally protozoan infections. In addition, they are used to cure several diseases such as strep throat, urinary tract infections, sinus infections, pneumonia, skin infections, ear infections, and others. There are numerous ways of classifying antibiotics, however, the most common classification is based on their chemical structures, spectrum of activity, and mode of action. Currently, the demand for beta lactam and beta lactamase inhibitors class of antibiotics is high among healthcare providers. The global antibiotics market generated $42,335 million in 2017, and is projected to reach $50,374 million by 2025, growing at a CAGR of 2.1% from 2018 to 2025.

 

The growth of the global antibiotics market is increasing due to increased consumption of antibiotics in low & middle-income countries, major investments in R&D activities by pharmaceutical companies, and rise in prevalence of infectious diseases. However, development of antibiotic resistance and increase in drug approval costs are projected to impede the market growth. On the contrary, discovery of advanced prospect molecules and introduction of novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer remunerative opportunities for market players.

 

Class segment review

Based on class, the market is classified into beta lactam & beta lactamase inhibitors, quinolones, macrolides, and others. Beta lactam & beta lactamase inhibitors segment is further divided into penicillin, cephalosporin, carbapenem, and monobactam. The beta lactam & beta lactamase inhibitors segment generated the highest revenue in 2017 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to its broad-spectrum activity, which heals infections caused due to multiple groups of bacteria. Thus, the demand for beta lactam & beta lactamase inhibitors is high among the healthcare providers and patients, which in turn fuels the growth of the global antibiotics market.

 

Spectrum of activity segment review

Based on the spectrum of activity, the market is bifurcated into broad-spectrum antibiotic and narrow-spectrum antibiotic. The broad-spectrum antibiotic segment is projected to exhibit the highest growth during the forecast period. This is attributed to the fact that broad-spectrum antibiotics act against a wide range of diseases, which in turn helps to combat antimicrobial resistance.

 

Region segment review

Region wise, the antibiotics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific dominated the market in 2017, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increased consumption of antibiotics, their easy availability, and rise in sale of over-the-counter drugs.

The report provides a comprehensive analysis of the key players operating in the global antibiotics market, namely, Abbott Laboratories, Allergan Plc., F.Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Mylan N.V., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd. The other players in the value chain include Aurobindo Pharma, Bayer HealthCare, Eli Lilly, Lupin Pharmaceuticals, Sun Pharmaceutical, Shionogi, and others.

Key Benefits for Antibiotics Market :

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.

  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

  • A comprehensive analysis of the factors that drive and restrain the growth of the global antibiotics market is provided.

  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

Antibiotics Market Report Highlights

Aspects Details
By Class
  • Beta Lactam & Beta Lactamase Inhibitors
    • Penicillin
    • Cephalosporin
    • Carbapenem
    • Monobactam
  • Quinolone
  • Macrolide
  • Others
By Drug Origin
  • Natural
  • Semisynthetic
  • Synthetic
By Spectrum Of Activity
  • Broad-spectrum Antibiotic
  • Narrow-spectrum Antibiotic
By Route Of Administration
  • Oral
  • Intravenous
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, Spain, Italy, UK, Rest of Europe)
  • Asia-Pacific  (Australia, Japan, India, China, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Sanofi, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Allergan Plc., Abbott Laboratories, Pfizer Inc., Novartis International AG (Sandoz), GlaxoSmithKline plc
 

Loading Table Of Content...


 
 

Antibiotic is a chemical compound of natural or semi-synthetic or synthetic origin, which inhibits the growth of bacteria and protozoans. Antibiotic is either produced by a microorganism (natural) or from a similar product produced wholly (synthetic) or partially (semisynthetic) by chemical synthesis.

The global antibiotics market is expected to exhibit significant growth during the forecast period, due to increased consumption in low- & middle-income countries and rise in prevalence of infectious diseases. In addition, development of novel approaches for new antibiotics to treat bacterial infections and increase in clinical trials supplement the market growth. However, low investment in R&D for the development of new antibiotics, time taken for regulatory approval, and increase in drug approval costs are expected to hinder the growth of the market.

The semisynthetic segment presently dominates the market attributable to the fact that the semisynthetic antibiotics possess improved coverage and effectiveness against a wide range of organisms. In addition, they can be administered either intravenously or orally or topically, and are lower cost to administer than other antibiotics, in some cases. However, the synthetic segment will grow with a highest rate during the forecast period, due to rise in need for synthetic membrane-targeted antibiotics due to antimicrobial resistance. Moreover, synthetic antibiotics have various advantages over existing antibiotics such as a broad spectrum of activity, no cross-resistance with the existing antibiotics, rapid bactericidal activity, and low probability to develop resistance.

Asia-Pacific was the leading revenue contributor to the global antibiotics market in 2017, and is expected to remain dominant throughout the forecast period, due to increase in consumption of antibiotics, easy availability of antibiotics, and rise in sale of over-the-counter drugs. However, LAMEA is expected to grow at the highest CAGR during the study period attributable to easy obtainability of antibiotics over the counter and no obligation on their usage in this region. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to high prevalence of infectious diseases and rise in demand for antibiotics.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample

Purchase Full Report of
Antibiotics Market

Start reading instantly.
This Report and over 53,681+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Oct 2019 - Oct 2020)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2019 - Oct 2020)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2019 - Oct 2020)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2019 - Oct 2020)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2019 - Oct 2020)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers